Purple BiotechPurple Biotech
  • Home
  • About us
    • Our History
    • Mission
    • Executive Team
    • Board of Directors
  • Pipeline
    • Overview
    • CM24
    • NT219
    • IM1240
    • Publications
  • Investors
    • Overview
    • News & Events
    • Press Releases
    • SEC Filings
    • Shareholders’ Meetings
    • Email Alerts
    • Corporate Governance
  • Contact us
menu
  • Home
  • About us
  • Pipeline
  • Investors
  • Contact Us
To Top

Category: Events

Categories

  • News and Events
    • Events
    • News
  • Publications
    • CM-24
    • more about CM-24
    • more about NT-219
    • NT-219

Posts

  • Purple Biotech’s CEO Gil Efron is featured in Pharma’s Almanac sharing his insights in a Q&A executive interview. Read the full Q&A here.
  • Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.
  • Purple Biotech CEO Gil Efron is featured in Drug Development and Delivery Magazine in a Q&A executive interview. Read the full interview.
  • Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.
  • Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023
  • CM24, a Novel Anti-CEACAM1 mAb, Suppresses Neutrophil Extracellular Trap (NET)-Induced Migration and Metastasis of Cancer Cells
  • Purple Biotech to participate and Present at the Jefferies London Healthcare Conference
  • Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis 
  • Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. – Click here to replay
  • Interim Safety and Efficacy Results from a Phase 1 Study of NT219 in Adults with Advanced Solid Tumors
Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.

Purple Biotech to attend the 17th annual BIO-Europe Spring taking place March 20-22, Basel, Switzerland.

By afri-can
in
Events
Mar 20, 2023

March 20 2023 at 8:00 am – March 22 at 5:00 pm – UTC+0

Read more
Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.

Purple Biotech will attend BIO CEO & Investors conference in NYC and will participate in the panel of “Market Outlook – Convincing Hesitant Investors for IPOs Versus Other Capital Alternatives”.

By afri-can
in
Events
Feb 01, 2023

February 6 2023 at 8:00 am – February 7 at 5:00 pm – UTC+0

Read more
Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023

Purple Biotech to participate at the 41st Annual J.P. Morgan week in San Francisco, 9-12 January, 2023

By afri-can
in
Events
Dec 11, 2022

January 9 2023 at 8:00 am – January 12 at 5:00 pm – UTC+0

Read more
Purple Biotech to participate and Present at the Jefferies London Healthcare Conference

Purple Biotech to participate and Present at the Jefferies London Healthcare Conference

By afri-can
in
Events
Nov 11, 2022

November 15 2022 at 8:00 am – November 17 at 5:00 pm – UTC+0

Read more
Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis 

Purple Biotech Presents New Data on Mechanism of Action for CM24 at the AACR Special Conference: Cancer Metastasis 

By afri-can
in
Events
Nov 08, 2022

November 14 2022 at 8:00 am – November 17 at 5:00 pm – UTC+0

Read more
Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. – Click here to replay

Purple Biotech to participate in a leadership call by Chardan Capital Markets LLC. – Click here to replay

By afri-can
in
Events
Nov 01, 2022

November 8 2022 at 8:00 am – 5:00 pm – UTC+0

Read more
Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022 annual meeting

Purple Biotech Presents Phase 1 Interim Monotherapy Data for NT219 at ASCO 2022 annual meeting

By afri-can
in
Events
May 29, 2022

June 5 2022 at 11:00 am – 11:00 am – UTC+0

Read more
Purple Biotech to present at the AACR annual meeting 2022

Purple Biotech to present at the AACR annual meeting 2022

By afri-can
in
Events
Apr 07, 2022

April 8 2022 at 8:00 am – 5:00 pm – UTC+0

Read more
Purple Biotech to participate in a Fireside Chat at BTIG Virtual Biotechnology Conference

Purple Biotech to participate in a Fireside Chat at BTIG Virtual Biotechnology Conference

By afri-can
in
Events
Jul 29, 2021

August 9 2021 at 8:00 am – August 10 at 5:30 pm – UTC+0

Read more
Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Annual Meeting

Purple Biotech to Present New Clinical Data from NT219 at the 2021 ASCO Annual Meeting

By afri-can
in
Events
Jun 02, 2021

June 4 2021 at 12:00 am – June 8 at 11:59 pm – UTC+0

Read more
1 2 Next »
Corporate Headquarters

4 Oppenheimer St.
Science Park, Rehovot
Israel 7670104
Tel : + 972-3-9333121

ir@purple-biotech.com

 

Follow Us
linkedin
Purple biotech
  • Investors
  • Pipeline
  • About us
  • Contact Us

2021 All Rights Reserved. Created BY ATEAS.BIZ

  • Home
Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset